Location History:
- Edmonton, CA (1998 - 2009)
- Alberta, CA (2010)
Company Filing History:
Years Active: 1998-2010
Title: Innovations and Contributions of Rao R Koganty
Introduction
Rao R Koganty is a notable inventor based in Edmonton, Canada. He has made significant contributions to the field of immunology through his innovative patents. With a total of 3 patents, Koganty has focused on developing novel therapeutic agents that have the potential to combat diseases caused by cancer cells and pathogens.
Latest Patents
Koganty's latest patents include groundbreaking work on immunostimulatory, covalently lipidated oligonucleotides. These oligonucleotides, which comprise the CpG dinucleotide unit or its analogues, serve as immunostimulatory agents. They can protect against diseases caused by cancer cells or pathogens, either alone or in conjunction with immunogens and/or non-immunological agents. His research highlights lipidated oligonucleotides with special backbones, those with fewer than eight nucleotides, and those containing multiple CpG dinucleotide segments connected by long internucleoside linkages. Additionally, Koganty has developed synthetic Lipid-A analogs based on monosaccharide and disaccharide derivatives. These analogs incorporate novel lipid structures that are not found in nature, showcasing his innovative approach to therapeutic formulations.
Career Highlights
Throughout his career, Koganty has worked with several prominent companies, including Biomira, Inc. and Oncothyreon Inc. His work in these organizations has allowed him to advance his research and contribute to the development of new therapeutic strategies.
Collaborations
Koganty has collaborated with notable colleagues such as Zi-Hua Jiang and Damayanthi Yalamati. These partnerships have further enriched his research and innovation in the field of immunology.
Conclusion
Rao R Koganty's contributions to immunology through his patents and collaborations highlight his role as a significant inventor in the field. His innovative approaches to developing therapeutic agents continue to pave the way for advancements in medical science.